Status: Finalised
First registered on:
05/07/2016
Last updated on:
20/08/2019
1. Study identification
EU PAS Register NumberEUPAS13959
Official titleCOMPARABILITY OF POPULATION DEFINITIONS WITHIN & BETWEEN GLOBAL DATABASES – DEVELOPING TOOLS FOR OBSERVATIONAL RESEARCH
Study title acronymACO Population Definitions
Study typeObservational study
Brief description of the studyThis initial phase—the focus of this study—intends to compare prevalence and agreement rates for the different ACO definitions between different national and international databases. As such, simple ACO definitions will be used to ensure they can be operationalized across a number of databases. As each database used will be specific to a patient population and (in most cases) to one country of origin, use of multiple databases affords a unique opportunity to examine the sensitivity of findings to how populations were included in different databases.
Future phases of the REG ACO Working Group’s research programme will go on to characterize the different ACO populations from a clinical perspective (cross sectionally and historically) and to explore potential differential treatment outcomes associated with the different definitions.
It is expected to be considerable variation in characterization approaches in the follow-on clinical characterisation and outcome evaluation phases (owing to differences in available variables and the requirement to use a range of proxy measures in order to optimise approaches within each database). As such, this work will be treated as a separate second study phase
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)?
Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Department/Research groupResearch in Real Life Ltd
Organisation/affiliationOPRI Pte Ltd
Details of (Primary) lead investigator
Title Dr
Last name Krishnan
First name Jerry
Is this study being carried out with the collaboration of a research network?
Yes
Other centres where this study is being conducted
Multiple centres
In total how many centres are involved in this Study?7
University of Groningen, Netherlands
University Hospital Vall d'Hebron, Spain
Adelphi Real World, UK
Primary Care Majorca Department, Spain
OPCRD, UK
Countries in which this study is being conducted
International study
Korea, Democratic People's Republic of
Netherlands
Poland
Spain
United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed31/08/201631/08/2016
Start date of data collection31/10/201631/10/2016
Start date of data analysis
Date of interim report, if expected
Date of final study report31/08/201731/08/2018
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government body
Research councils
EU funding scheme
OtherREG100
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Krishnan
First name Jerry
Address line 1University of Illinois Hospital and Health Sciences System
Address line 2
Address line 3
CityChicago
Postcode
CountryUnited States
Phone number (incl. country code)4401223967582
Alternative phone number
Fax number (incl. country code)
Public Enquiries
Title Dr
Last name Krishnan
First name Jerry
Address line 1University of Illinois Hospital and Health Sciences System
Address line 2
Address line 3
CityChicago
Postcode
CountryUnited States
Phone number (incl. country code)4401223967582
Alternative phone number
Fax number (incl. country code)
6. Study drug(s) information
Not applicable (disease/epidemiology study)
7. Medical conditions to be studied
Medical condition(s)Yes
Chronic obstructive pulmonary disease
Asthma
Asthma-chronic obstructive pulmonary disease overlap syndrome
8. Population under study
Age
Children (2 - 11 years)
Adolescents (12 - 17 years)
Adults (18 - 44 years)
Adults (45 - 64 years)
Adults (65 - 74 years)
Adults (75 years and over)
Sex
Male
Female
9. Number of subjects
Estimated total number of subjects50000
10. Source of data
Is this study being carried out with an established data source?Yes
Data sources registered with ENCePP
Data sources not registered with ENCePP
Dutch Asthma/COPD Service Database, Netherlands
Adelphi Respiratory Database, United Kingdom
MAJorca Real-world investigation, Spain
Sources of data
Administrative database, e.g. claims database
Routine primary care electronic patient registry
11. Scope of the study
What is the scope of the study?
Disease epidemiology
Primary scope : Disease epidemiology
12. Main objective(s)
What is the main objective of the study?
To inform standardised methods for future ACO observational research, the study aims to: test various smoking-related ACO population definitions (based on previous evidence), evaluating their respective prevalence and agreement (i) within and (ii) between a number of national and international research quality databases
Are there primary outcomes?Yes
The primary outcomes of the study are the prevalence of subpopulations B and C, relative to A within each of the parent population series (COPD, ACOS, Asthma, Control) and the agreement within each database between the most selective subpopulations’ definitions within each parent series (i.e. subpopulation C) and between different databases
Are there secondary outcomes?No
13. Study design
What is the design of the study?
Observational, historical database study
14. Follow-up of patients
Will patients be followed up?Not applicable/no follow-up
15. Data analysis plan
Please provide a brief summary of the analysis method
Evaluation of:
1. Outcome 1 (total number of patients) will require absolute count of patient numbers.
2. Outcome 2 (population prevalence) will require evaluation of the percent prevalence within different Parent Series.
3. Outcomes 3 & 4 (agreement across different population definitions: 1C vs 2C vs 3C vs 4C) will use the kappa statistic (k) or suitable alternatives (e.g., Chi-squared)
16. ENCePP seal
Are you requesting the ENCePP seal for this study?
No
17. Full protocol
Not submitted
18. Study Results
Not submitted
Please list the 5 most relevant publications using data from your study
ReferenceLink to web-publication
Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JF, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, van Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK, Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, Roche N.Prevalence and Characteristics of Asthma-COPD Overlap in Routine Primary Care Practices.Ann Am Thorac Soc. 2019 Jun 4.https://doi.org/10.1513/AnnalsATS.201809-607OC
19. Other relevant documents
Conflict(s) of interest of
investigator(s)Not submitted
Composition of Steering Group and
ObserversNot submitted
Other documentsNot
submitted
Signed Code of
Conduct Checklist
Not submitted
Signed Code of Conduct Declaration
Not submitted
Signed Checklist for Study
Protocols
Not submitted
